Transgenic mice with SERT overexpression were more susceptible to pulmonary hypertension [104], and administering SERT inhibitors prevented hypoxia-induced pulmonary vascular remodeling in wild-type animals [105]. This evidence concerns the gene SLC6A4 and pulmonary hypertension.